Analgesia, Anaesthesia and Pregnancy: A Practical Guide / Edition 2 available in Paperback
- Pub. Date:
- Cambridge University Press
|Publisher:||Cambridge University Press|
|Product dimensions:||5.98(w) x 8.98(h) x 0.87(d)|
About the Author
Anne May is a Consultant Obstetric Anaesthetist at Leicester Royal Infirmary NHS Trust and Honorary Senior Lecturer at the University of Leicester.
Surbhi Malhotra is a Clinical Fellow in Obstetric Anaesthesia at Chelsea and Westminster Hospital, London.
Read an Excerpt
Cambridge University Press
978-0-521-69474-2 - Analgesia, Anaesthesia and Pregnancy: A Practical Guide - by Steve Yentis, Anne May and Surbhi Malhotra
Section 1 - Preconception and Conception
1 ASSISTED CONCEPTION
There have been rapid developments in the treatment of infertility. The anaesthetist may be involved in many aspects of the patient's treatment, which may be complex. The harvesting of oocytes needs to take place within a defined period of time, or ovulation will have occurred and oocytes will be lost. Couples presenting for infertility treatment are generally anxious and often the women are emotional at the time of oocyte retrieval. It is therefore particularly important for the anaesthetist to understand the couple's anxieties and to be able to explain the effects of the anaesthetic technique that is to be used.
All of the techniques involve extraction of oocytes from the follicles, either laparoscopically or, with the development of transvaginal ultrasonography, via the transvaginal route (ultrasound directed oocyte retrieval, UDOR). The techniques differ in the site of fertilisation and/or replacement of the gamete/zygote:
The main considerations for laparoscopy are the type of anaesthesia, the pneumoperitoneum and the effects of the anaesthetic agents on fertilisation and cell cleavage. The length of exposure to the drugs is also important. The effects of nitrous oxide and volatile anaesthetic agents on fertilisation and cleavage rates have been extensively examined. It is generally recognised that all the volatile agents and nitrous oxide have a deleterious effect, although opinion is divided as to the extent of the problem. It is also recognised that the carbon dioxide used for the pneumoperitoneum causes a similar effect, and it is difficult to separate the effects of the anaesthetic agents from those of the carbon dioxide.
Of the intravenous agents, the effect of propofol on fertilisation and cleavage appears to be minimal. Propofol accumulates in the follicular fluid, and the amount in the follicular fluid may become significant if there are a large number of oocytes to retrieve. Propofol decreases the fertilisation rates but there is no significant effect on the cell division rates.
All assisted conception techniques carry the risk of ovarian hyperstimulation (see Chapter 2, Ovarian hyperstimulation, p. 3), and multiple or ectopic pregnancy.
It would be logical to use regional anaesthesia wherever possible, although this is often not well suited for laparoscopy. The development of the transvaginal route for oocyte retrieval has increased the possibility of using regional anaesthesia.
For patients requiring laparoscopy, it would seem sensible to minimise the use of drugs. This has led to the increased use of propofol as the main agent in total intravenous anaesthesia.
For UDOR, which has become the most common method used for oocyte retrieval, the main anaesthetic techniques are intravenous sedation and regional anaesthesia. It is important to remember that patients requiring UDOR are day cases and the basic principles of day-case anaesthesia apply. There has been a considerable amount of work to date on the use of propofol with alfentanil, and this drug combination would appear to be the technique of choice for intravenous sedation. The propofol may be administered by intermittent boluses or by continuous infusion, with the patient breathing oxygen via a Hudson mask. Many anaesthetists find that they are using levels of sedation close to anaesthesia. It is essential that the sedation is administered in a suitable environment with resuscitation facilities and anaesthetic monitoring. Often the assisted conception unit is some distance from the main theatre suite; therefore it is important for the staff working in an isolated environment to maintain their skills in resuscitation.
The aim of minimising the drugs administered to women undergoing ultrasound-guided techniques has led to the use of regional anaesthesia. The main problem lay in developing techniques that allow the woman to go home the same day. Epidural and spinal anaesthesia have both been used with success, particularly where early ambulation is not essential. The low-dose spinal technique that is used for labour analgesia has been shown to give good operating conditions and to satisfy the criteria needed for day-case anaesthesia; it may be some way to achieving an ideal in this difficult group of patients.
Post-procedure analgesia may be provided with non-steroidal anti-inflammatory drugs such as diclofenac.
Tidmarsh MD, May AE. Spinal analgesia for transvaginal oocyte retrieval. Int J Obstet Anesth 1998; 7: 15760.
Viscomi CM, Hill K, Johnson J, Sites C. Spinal anaesthesia versus sedation for transvaginal oocyte retrieval: reproductive outcome, side effects and recovery profiles. Int J Obstet Anesth 1997; 6: 4951.
Yasmin E, Dresner M, Balen A. Sedation and anaesthesia for transvaginal oocyte collection: an evaluation of practice in the UK. Hum Reprod 2004; 19: 29425.
2 OVARIAN HYPERSTIMULATION SYNDROME
Ovarian hyperstimulation syndrome is associated with the medical stimulation of ovulation necessary for in vitro fertilisation. It occurs 38 days after treatment with human chorionic gonadotrophin (hCG), and the effects continue throughout the luteal phase. The active ingredient causing the syndrome via increased capillary permeability is thought to be secreted from the ovaries, and both histamine and prostaglandins have been implicated.
Clinical manifestations of the syndrome are:
Additional complications that may occur are:
Table 2.1. Grading of ovarian hyperstimulation syndrome
|Grade|| Features|| || Incidence|
|1||Abdominal distension and discomfort|
|2||Grade 1 plus nausea, vomiting and diarrhoea|
|3||Grade 2 plus ascites (detected by ultrasonography)||18%|
|4||Grade 3 plus clinical ascites and shortness of breath|
|5||Grade 4 plus clinical hypovolaemia, haemoconcentration, coagulation defects, decreased renal perfusion therefore urea and electrolyte disturbance, thromboembolic phenomena|
Women undergoing ovarian stimulation who develop ovarian hyperstimulation syndrome can be assessed by placing them in one of five grades according to presenting symptoms and signs (Table 2.1).
When a large number of eggs (>20) have been retrieved, ovarian hyperstimulation should be suspected and the patient monitored. This may involve hospital admission.
Once suspected, the diagnosis of ovarian hyperstimulation syndrome can be confirmed by:
Immediate treatment is to stop hCG administration and to aspirate the enlarged follicles. Mild forms of ovarian hyperstimulation syndrome will be self-limiting, but those women graded 3 or worse will require intravenous fluids to correct the hypovolaemia and haemoconcentration. The intravenous administration of 1000 ml of human albumin is recommended at the time of oocyte retrieval if hyperstimulation is suspected.
In women graded 4 and 5, dopamine has been given to improve renal perfusion. In addition, it may be advisable to drain the ascitic fluid and to consider anticoagulation. Ultrafiltration and intravenous reinfusion of ascitic fluid has been used in severe cases.
Monitoring is tailored to the severity of the syndrome, and the following progression is recommended:
Shanbhag S, Bhattacharya S. Current management of ovarian hyperstimulation syndrome. Hosp Med 2002; 63: 52832.
Whelan JG 3rd, Vlahos NF. The ovarian hyperstimulation syndrome. Fertil Steril 2000; 73: 88396.
3 ANAESTHESIA BEFORE CONCEPTION OR CONFIRMATION OF PREGNANCY
Many women will require anaesthesia when they are pregnant and many will be unaware that they are pregnant at the time of the anaesthetic, especially in the first 23 months of their pregnancy. The thalidomide catastrophe initiated the licensing arrangements for new drugs and their use in pregnancy; the current cautious stance of the pharmaceutical industry is reflected in the British National Formulary's statement that no drug is safe beyond all doubt in early pregnancy. The anaesthetist should have a clear knowledge of the time scale of the developing fetus in order to balance the risks and benefits of any drug given to the mother. A teratogen is a substance that causes structural or functional abnormality in a fetus exposed to that substance.
The possible effect of a drug can be considered against the stage of the developing fetus:
The anaesthetist should always consider the possibility of pregnancy in any woman of child-bearing age who presents for surgery, whether elective or emergency, and should specifically enquire in such cases. If there is doubt, a pregnancy test should be offered. If pregnancy is suspected, the use of nitrous oxide is now generally considered acceptable, despite its effects on methionine synthase and DNA metabolism, as there is little evidence that it is harmful clinically. Similarly, although the volatile agents have been implicated in impairing embryonic development, clinical evidence is lacking. Some drugs cross the placenta and exert their effect on the fetus, e.g. warfarin, which may cause bleeding in the fetus.
Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med 1998; 338: 112837.
Section 2 - Pregnancy
I Procedures in early/mid-pregnancy
4 CERVICAL SUTURE (CERCLAGE)
Cervical suture (Shirodkar or McDonald cerclage) is performed to reduce the incidence of spontaneous miscarriage when there is cervical incompetence. Although it can be done before conception or as an emergency during pregnancy, the procedure is usually performed electively at 1216 weeks' gestation; it generally takes 1020 minutes and is performed transvaginally on a day-case basis. A non-absorbable stitch or tape is sutured in a purse-string around the cervical neck at the level of the internal os; this requires anaesthesia since the procedure is at best uncomfortable, although the suture can usually be removed easily without undue discomfort (usually at 3738 weeks' gestation unless in preterm labour); spontaneous labour usually soon follows.
In patients with a grossly disrupted cervix, e.g. following surgery, placement of the suture via an abdominal approach may be required. Delivery is usually by elective Caesarean section in these cases.
Women undergoing cervical suturing may be especially anxious since previous pregnancies have ended in miscarriage. Otherwise anaesthesia is along standard lines, bearing in mind the risks of anaesthesia in the pregnant woman and monitoring of, and possible effects of drugs on, the fetus (see Chapter 7, Incidental surgery in the pregnant patient, p. 12).
Cerclage may be difficult if the membranes are bulging; the head-down position and/or tocolysis may be requested to counter this.
Many authorities advocate spinal anaesthesia as the technique of choice since only a small amount of a single drug is administered, although epidural anaesthesia is also acceptable. If spinal or epidural anaesthesia is chosen, standard techniques are used. The procedure itself requires a less extensive block than Caesarean section (from T810 down to and including the sacral roots) and thus smaller doses are required; however, the reduction is offset by the greater requirements at this early stage of pregnancy compared with the term parturient. Thus the doses required for regional anaesthesia are in the order of 75% of those used for Caesarean section. Low-dose techniques have also been used, as for Caesarean section; the women have more sensation (though painless) but have less motor block.
General anaesthesia may also be used; an advantage is the relaxing effect of volatile agents on the uterus, but it does usually involve administration of more than one drug, and the effects on the fetus of many agents in current use are not clear. There may also be an increased risk of regurgitation and aspiration of gastric contents, depending on the gestation and severity of symptoms (see Chapter 56, Aspiration of gastric contents; p. 138).
Paracervical and pudendal block and/or intravenous analgesia/sedation may also be used, but most authorities would recommend avoiding paracervical block because of the potential adverse effects on uteroplacental perfusion.
Drakeley AJ, Roberts D, Alfirevic Z. Cervical stitch (cerclage) for preventing pregnancy loss in women (Cochrane Review). In: The Cochrane Library, Issue 4, 2003. Chichester, UK: John Wiley & Sons, Ltd.
5 ECTOPIC PREGNANCY
There are approximately 11 000 ectopic pregnancies per year in the UK (just over 1% of all pregnancies), and the incidence is thought to be increasing as a result of pelvic inflammatory disease. There are many risk factors, with tubal pathology or surgery and use of an intrauterine device the most important; others are infertility, increased maternal age and smoking. About 35 women die as a consequence in the UK per year, representing about 36% of all direct maternal deaths (~1 per 2500 ectopics). Most ectopic pregnancies occur in the Fallopian tube, but up to 5% occur elsewhere within the genital tract or abdomen. Typically, the tube initially expands to accommodate the growing zygote but when unable to do so any more, there may be bleeding from the site of implantation or even rupture of the tube. Thus the classic presentation is with abdominal pain, which may be sudden in onset, accompanied by a history of amenorrhoea (although there is vaginal bleeding at presentation in ~80% of cases). There may be sudden collapse if the tube ruptures, caused by reflex vagal activity or hypovolaemia if bleeding is severe, or both.
The main risk of ectopic pregnancy is sudden severe haemorrhage, which may be intra-abdominal and thus concealed until rapid decompensation and collapse occur. A common theme in deaths associated with ectopic pregnancy is the failure to consider the diagnosis before collapse. Ectopic pregnancy may present with non-specific abdominal signs including diarrhoea or constipation, thus mimicking other intra-abdominal conditions (e.g. appendicitis), although with serial measurement of plasma human chorionic gonadotrophin (hCG; doubles every 23 days in normal pregnancy) and use of pelvic ultrasonography this should be unusual. The potential severity of the condition is not always appreciated by other hospital staff, the patient herself or her relatives. Ectopics outside the Fallopian tubes are more likely to be associated with massive haemorrhage, with abdominal pregnancies the most hazardous, especially when the placenta is removed.
Most ectopic pregnancies present early in pregnancy and thus many of the physiological changes of pregnancy are absent or mild the patient may even be unaware that she is pregnant. However, even at this early stage there may be features of the physiological changes of pregnancy.
The implications for the current and future pregnancies pose a great psychological stress on the patient and her partner. There may be a previous history of ectopic pregnancy since its occurrence is itself a risk factor for subsequent ectopics.
Initial management is directed at treating and preventing massive haemorrhage; thus the patient requires at least one large-bore intravenous cannula and careful observation at least until the diagnosis has been excluded. Similarly, once the decision to operate has been made it needs to occur as soon as possible, since the risk of rupture is always present.
Operative management usually involves laparoscopy unless there is severe haemodynamic instability, in which case laparotomy is performed. Traditionally, laparoscopy was performed purely for diagnostic purposes, but laparoscopic removal of the zygote with or without tubal resection has become routine in many units. Anaesthetic aspects of the procedure itself are as for any laparoscopic operation.
Anaesthetic management is as for any emergency surgery, given the above considerations. Haematological assistance and admission to the intensive care unit should be available if required. In severe cases, anaesthesia must proceed as for a ruptured aortic aneurysm: full preoperative resuscitation may be impossible and the patient is prepared and draped before induction of anaesthesia, which may be followed by profound hypotension.
In some countries, medical management is increasingly used as the first-line treatment of early ectopic pregnancies, with intramuscular methotrexate. The drug antagonises folic acid and prevents further growth of the trophoblast, which is especially vulnerable at this early stage. Similar outcome to that following surgical management has been claimed. Local injection of hyperosmolar glucose, prostaglandin and potassium chloride have also been used. Finally, expectant management has been used in selected patients, although women whose pregnancies are self-limiting cannot yet be identified reliably.
Pisarska MD, Carson SA, Buster JE. Ectopic pregnancy. Lancet 1998; 351: 111520.
Tay JI, Moore J, Walker JJ. Ectopic pregnancy. BMJ 2000; 320: 91619.
6 EVACUATION OF RETAINED PRODUCTS OF CONCEPTION
Evacuation of retained products of conception (ERPC) may be required at any stage of pregnancy, but it occurs most commonly in early pregnancy following incomplete miscarriage or early fetal demise. It is also required during the puerperium following retention of placental tissue (see Chapter 41, Removal of retained placenta, p. 107).
FURTHER READINGRoyal College of Obstetricians and Gynaecologists. The management of early pregnancy loss. London: RCOG, 2000.
7 INCIDENTAL SURGERY IN THE PREGNANT PATIENT
Pregnant women may present with the same surgical conditions as the non-pregnant population, or with problems related to their pregnancy. Most pregnant women are relatively young and fit, although there are an increasing number of women with systemic disease who are becoming pregnant because of advances in medical or surgical management of their condition. Points of particular relevance to anaesthetists are therefore any underlying condition in addition to the reason for surgery, the effects of pregnancy on its management and the effect upon the fetus.
In general, surgery is delayed until the second trimester if possible, because the major fetal organs will have already developed; in addition, the risk of premature labour is lower and the surgery easier than in the third trimester.
Perioperative management requires attendance by senior surgical and obstetric staff, with investigations and scans as required.
Anaesthetic management includes preoperative assessment of the airway and antacid pretreatment. The supine position should be avoided at all times, although the efficacy of lateral tilt when the uterus is still small is uncertain. Particular attention should be paid to general assessment as for emergency surgery in any patient. The disadvantages of regional anaesthesia (e.g. hypotension, increased peristalsis, problems with managing the block during difficult or prolonged surgery) must be weighed against those of general anaesthesia (airway problems, risk of awareness, etc.). Although general anaesthesia involves administration of more drugs with possible effects on the fetus, it also allows administration of volatile agents that relax the uterus. In general, drugs with good safety records during pregnancy should be used; most anaesthetic drugs do not have licences for use in pregnancy (mainly because of the costs involved in extending their licences), but newer drugs should probably be avoided until more is known about their actions. The only standard anaesthetic drug that has excited controversy in recent years is nitrous oxide, because of its effects on methionine synthase and DNA metabolism. Although there is a theoretical risk of its affecting the fetus, there is no evidence to support this clinically and many, if not most, authorities would now consider its use acceptable. General anaesthetic management would thus usually consist of rapid sequence induction with standard agents, tracheal intubation and ventilation of the lungs with a volatile agent, as for any emergency general anaesthetic. Other drugs would be used as standard, but those that might increase uterine tone (e.g. ketamine, β-blockers) or vasoconstriction should be avoided if possible. Many obstetricians would request prophylactic administration of tocolytic drugs perioperatively. β-Adrenergic agonists are commonly used for this purpose, although their efficacy in this situation is uncertain and they may cause maternal tachycardia and pulmonary oedema; recent evidence suggests that calcium-channel blockers such as nifedipine may be at least equally effective with a better safety profile. In general, probably the fewer drugs used overall the better. Certain drugs given near to delivery may cross the placenta and affect the fetus, e.g. non-steroidal anti-inflammatory drugs (which can prevent the ductus arteriosus from closing).
Traditional fears about the detrimental effects of high levels of maternal oxygen by causing uteroplacental vasoconstriction are now known to be unfounded, and fetal arterial partial pressure of oxygen increases (up to a maximum of about 8 kPa (60 mmHg)) as maternal arterial oxygen content increases, so long as maternal hypotension is avoided. Maternal arterial partial pressure of carbon dioxide should be kept in the normal (pregnant) range during controlled ventilation.
The fetus must be monitored preoperatively and postoperatively. Intraoperative monitoring is controversial and may be difficult if the surgery is abdominal; it may be possible to use a sterile sleeve over an ultrasonic/Doppler probe. It may be difficult to arrange appropriate midwifery and surgical nursing care both before and after surgery, and the most appropriate area for the mother's postoperative care needs careful consideration.
Melnick DM, Wahl WL, Dalton VK. Management of general surgical problems in the pregnant patient. Am J Surg 2004; 187: 17080.
Mhuireachtaigh RN, O'Gorman DA. Anesthesia in pregnant patients for nonobstetric surgery. J. Clin. Anesth 2006; 18: 606.
Rosen M. Management of anesthesia for the pregnant surgical patient. Anesthesiology 1999; 91: 115963.
8 INTRAUTERINE SURGERY
Fetal surgery is an option in cases where an isolated abnormality would be otherwise fatal to the fetus or neonate, and is clearly amenable to correction, e.g. neck tumours with airway obstruction, sacrococcygeal teratomas, obstructive uropathy and diaphragmatic hernia. However, results of intrauterine surgery have been conflicting and there is no clear consensus on its place. Simpler measures, e.g. intrauterine blood transfusion in haemolytic disease, are more widely accepted.
Each procedure must be assessed on a riskbenefit basis, since there is a risk of up to 50% fetal loss associated with premature labour, haemorrhage, abruption and infection. For open procedures, vertical uterine incision is required, with Caesarean section to deliver the baby if pregnancy proceeds. Maternal thromboembolism has been reported. Thus each lesion must be carefully defined and a chromosomal abnormality or other malformation excluded. For example, intrauterine placement of intraventricular shunts is no longer considered suitable for treatment of hydrocephalus, since the riskbenefit ratio cannot be calculated for individual fetuses because of the difficulty in predicting outcome antenatally. Since most conditions that might be amenable to intrauterine surgery are rare or uncommon and already associated with poor outcome, it is difficult to demonstrate that outcome after fetal surgery is better than that after conventional postpartum therapy, because any expected improvement will be small.
Surgery is technically difficult because of the small size of the fetus and its mobility when small, but leaving the surgery until later may result in increased end-organ damage caused by the malformation. The optimal timing for most procedures is uncertain, although most open ones have been performed at around 1824 weeks. Percutaneous procedures, e.g. transfusions, may be performed later or at intervals. The EXIT procedure (ex utero intrapartum therapy), for airway obstruction, is also done later and involves delivery of the fetal head through an open hysterotomy and tracheal intubation or tracheostomy while the fetus is oxygenated by the placenta. The fetus may then be delivered and undergo corrective surgery.
After intrauterine surgery, the mother may be confined to bed and receive β2-agonists, with the risks of deep vein thrombosis and pulmonary oedema respectively.
Anaesthetic management is along the lines of that for incidental surgery during pregnancy. Local anaesthetic infiltration of the abdominal wall may be adequate for percutaneous procedures, although there may be a need for emergency Caesarean section if fetal bradycardia occurs, and so adequate preparation and facilities are required for this. Regional anaesthesia is a suitable alternative if extensive percutaneous procedures are required.
Fetal and maternal general anaesthesia for corrective surgery is administered by using standard techniques. Fetal injection of a neuromuscular blocking drug may be required to stop fetal movement. Analgesics may also be injected into the fetus there is increasing evidence that the fetus can 'experience' pain, although the significance of this is disputed. Uterine relaxation has been achieved by using one or more of volatile agents, magnesium sulphate or glyceryl trinitrate. Fetal monitoring may be difficult but pulse oximetry, ultrasonography and cardiotocography have been used. Bleeding may be excessive in prolonged open procedures.
Farmer D. Fetal surgery. BMJ 2003; 326: 4612.
Kimber C, Spitz L, Cuschieri A. Current state of antenatal in-utero surgical interventions. Arch Dis Child 1997; 76: F1349.
Myers LB, Cohen D, Galinkin J, Gaiser RC, Kurth D. Anaesthesia for fetal surgery. Paediatric Anaesthesia 2002; 12: 56978.
9 TERMINATION OF PREGNANCY
Termination of pregnancy in the UK is undertaken under the terms and conditions of the Abortion Act 1967. For the consideration of anaesthetic procedures and potential problems, patients presenting for a termination of pregnancy broadly fall into two groups:
The presence of a maternal problem, the most commonly stated reason being danger to the mental or physical health of the mother
Severe fetal congenital abnormality or early fetal death.
When caring for women who are to undergo a termination of pregnancy, it is important to consider the physiological changes of pregnancy, the psychological state of the woman and the need for routine preoperative assessment of the patient.
Those women in the first group above are usually scheduled to have termination of pregnancy on a gynaecological operating list. The second group of patients are often looked after in the maternity unit.
Some members of staff may express conscientious objection to performing or being involved in termination of pregnancy and this must be respected. They cannot be made to participate in such procedures, although they do have a duty to find other staff who will, if that is the patient's wish.
Termination for maternal indications
Termination of pregnancy is usually a day-case procedure, and routine preoperative assessment is undertaken immediately preoperatively. Assessment should be conducted sympathetically as these women are often very distressed.
Gestation is usually less than 15 weeks and these women can usually be regarded as non-pregnant with respect to gastric emptying and acid aspiration unless they have symptoms of reflux.
An anaesthetic technique suitable for day-case anaesthesia should be employed, e.g. induction with propofol followed by nitrous oxide/oxygen and maintenance with propofol or a volatile anaesthetic agent. There has been concern about concentrations of volatile anaesthetic agents greater than one minimum alveolar concentration causing uterine relaxation unresponsive to oxytocics. For a termination of pregnancy at less than 15 weeks, standard concentrations of volatile anaesthetic agents do not appear to pose a risk and may be used to maintain anaesthesia. Analgesia may be provided by intravenous fentanyl or alfentanil with rectal diclofenac 100 mg.
The gynaecologist may request that 510 U Syntocinon is administered to aid uterine contraction. There is no clear evidence that this is helpful at this stage of pregnancy.
Termination for fetal abnormality or death
Women who present for termination of pregnancy because of fetal abnormality or intrauterine death present a difficult clinical problem. Induction of labour is usually required and this may be a long and tedious process involving the use of prostaglandin pessaries and Syntocinon infusion (see Chapter 71, Intrauterine death, p. 170).
Termination of a pregnancy at less than 28 weeks is often associated with the retention of products of conception, for which surgical evacuation and anaesthesia are required. Either regional or general anaesthesia may be offered to the woman, balancing the risks and benefits of each depending on the clinical condition and whether epidural analgesia is already in place. Rapid sequence induction and tracheal intubation may be appropriate.
Analgesia, Anaesthesia and Pregnancy: A Practical Guide Second Edition, ed. Steve Yentis, Anne May and Surbhi Malhotra. Published by Cambridge University Press. © Cambridge University Press 2007.
© Cambridge University Press
Table of Contents1. Assisted conception; 2. Ovarian hyperstimulation syndrome; 3. Anaesthesia before conception or confirmation of pregnancy; 4. Cervical suture (cerclage); 5. Ectopic pregnancy; 6. Evacuation of retained products of conception; 7. Incidental surgery in the pregnant patient; 8. Intrauterine surgery; 9. Termination of pregnancy; 10. Anatomy of the spine and peripheral nerves; 11. Physiology of pregnancy; 12. Aortocaval compression; 13. Normal labour; 14. Gastric function and feeding in labour; 15. Drugs and pregnancy; 16. Placental transfer of drugs; 17. Prescription and administration of drugs by midwives; 18. Local anaesthetics; 19. Antenatal fetal monitoring; 20. Charting of labour; 21. Intrapartum fetal monitoring; 22. Pain of labour; 23. Epidural analgesia for labour; 24. Epidural test doses; 25. Combined spinal-epidural analgesia and anaesthesia; 26. Spinal analgesia; 27. Caudal analgesia; 28. Spinal and epidural opioids; 29. Inhalational analgesic drugs; 30. Systemic analgesic drugs; 31. Non-pharmacological analgesia; 32. Instrumental delivery; 33. Caesarian section; 34. Epidural anaesthesia for Caesarian section; 35. Spinal anaesthesia for Caesarean section; 36. General anaesthesia for Caesarean section; 37. Cricoid pressure; 38. Failed and difficult intubation; 39. Awake intubation; 40. Post-Caesarean section analgesia; 41. Removal of retained placenta; 42. Bloody tap; 43. Dural puncture; 44. Postdural puncture headache; 45. Epidural blood patch; 46. Extensive regional blocks; 47. Inadequate regional analgesia in labour; 48. Backache; 49. Horner's syndrome and cranial nerve palsy; 50. Peripheral nerve lesions following regional anaesthesia; 51. Spinal cord lesions following regional anaesthesia; 52. Arachnoiditis; 53. Cauda equina syndrome; 54. Opioid-induced pruritus; 55. Shivering; 56. Aspiration of gastric contents; 57. Awareness; 58. Air embolism; 59. Induction and augmentation of labour; 60. Oxytocic and tocolytic drugs; 61. Premature labour, delivery and rupture of membranes; 62. Malpresentations and malpositions; 63. External cephalic version; 64. Multiple pregnancy; 65. Trial of scar; 66. Under-age pregnancy and advanced maternal age; 67. Placenta praevia; 68. Placental abruption; 69. Prolapsed cord; 70. Fetal distress; 71. Intrauterine death; 72. Uterine inversion; 73. Major obstetric haemorrhage; 74. Postpartum haemorrhage; 75. Collapse on labour ward; 76. Maternal cardiopulmonary resuscitation; 77. Amniotic fluid embolism; 78. Cholestasis of pregnancy (obstetric cholestasis); 79. Acute fatty liver of pregnancy; 80. HELLP syndrome; 81. Hypertension, pre-eclampsia and eclampsia; 82. Magnesium sulphate; 83. Hyperemesis gravidarum; 84. Maternal mortality; 85. Allergic reactions; 86. Cardiovascular disease; 87. Arrhythmias; 88. Pulmonary oedema; 89. Cardiomyopathy; 90. Coarctation of the aorta; 91. Prosthetic heart valves; 92. Congenital heart disease; 93. Pulmonary hypertension and Eisenmenger's syndrome; 94. Ischemic heart disease; 95. Endocrine disease; 96. Diabetes mellitus; 97. Anaemia and polycythaemia; 98. Deep-vein thrombosis and pulmonary embolism; 99. Thrombophilia; 100. Coagulopathy; 101. Von Willebrand's disease and haemophilia; 102. Disseminated intravascular coagulation; 103. Thrombocytopenia; 104. Lymphoma and leukaemia; 105. Haemoglobinopathies; 106. Rheumatoid arthritis; 107. Cervical spine disorders; 108. Kyphoscoliosis; 109. Low back pain; 110. Neurological disease; 111. Meningitis; 112. Acute post-infective peripheral neuropathy (Guillain-Barré syndrome); 113. Past history of neurological trauma; 114. Benign intracranial hypertension; 115. Intracranial tumour; 116. Cerebrovascular accident; 117. Epilepsy; 118. Migraine; 119. Multiple sclerosis; 120. Myasthenia gravis; 121. Spina bifida; 122. Convulsions; 123. Respiratory disease; 124. Asthma; 125. Cystic fibrosis; 126. Pulmonary fibrosi